Neothetics Inc. (NEOT) Sank To A 10-Month Low After Phase 2 Study Failed

Neothetics Inc. (NEOT) announced Monday morning that its Phase 2 trial of LIPO-202-CL-31 did not show improvement on any efficacy measurements compared to placebo.

from RTT - Before the Bell http://ift.tt/2tfnB6b
via IFTTT